冠昊生物: 关于收到深圳证券交易所《关于终止对冠昊生物科技股份有限公司申请向特定对象发行股票审核的决定》的公告

Core Viewpoint - The company has decided to terminate its application for a specific stock issuance and has withdrawn the application documents as per the decision from the Shenzhen Stock Exchange [1][2]. Group 1 - The company held its sixth board meeting and sixth supervisory board meeting on June 23, 2025, where it approved the resolution to terminate the specific stock issuance and withdraw the application [1]. - The Shenzhen Stock Exchange issued a decision to terminate the review of the company's application for a specific stock issuance based on relevant regulations [2]. - The company has submitted a request to withdraw its application for the specific stock issuance and listing on the Growth Enterprise Market [1][2].